FDA.report

Ciprofloxacin

Product NDC
50090-5505
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ciprofloxacin
Dosage form
TABLET, COATED
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA208921
Marketing category
ANDA
Substance
CIPROFLOXACIN HYDROCHLORIDE
Current FDA listing
Historical FDA.report record

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
50090-5505-06 TABLET, COATED in 1 BOTTLE (50090-5505-0) 2021-04-070000-00-00NoCurrent
50090-5505-114 TABLET, COATED in 1 BOTTLE (50090-5505-1) 2021-04-070000-00-00NoCurrent
50090-5505-210 TABLET, COATED in 1 BOTTLE (50090-5505-2) 2021-04-070000-00-00NoCurrent
50090-5505-33 TABLET, COATED in 1 BOTTLE (50090-5505-3) 2021-04-070000-00-00NoCurrent

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN TABLETS, for oral use Initial U.S. Approval: 1987A-S Medication Solutions2021-04-12HUMAN PRESCRIPTION DRUG LABEL1